Fentrazamide metabolite solution
CAS : 98377-35-6
Ref. 3D-YDA37735
| 5mg | Arrêté | ||
| 10mg | Arrêté | ||
| 25mg | Arrêté | ||
| 50mg | Arrêté | ||
| 100mg | Arrêté |
Informations sur le produit
- 1-(2-Chloro-phenyl)-1,2-dihydro-tetrazol-5-one
- 1-(2-Chloro-phenyl)-1,4-dihydro-5H-tetrazol-5-one
- 1-(2-Chlorophenyl)-1H-tetrazol-5(4H)-one
- 1-(2-Chlorophenyl)-4,5-dihydro-1H-1,2,3,4-tetrazol-5-one
- 1-(2-Chlorophenyl)-5(4H)-tetrazolinone
- 1-(2-chlorophenyl)-1,4-dihydro-5H-tetraazol-5-one
- 5H-Tetrazol-5-one, 1-(2-chlorophenyl)-1,2-dihydro-
- 5H-tetrazol-5-one, 1-(2-chlorophenyl)-1,4-dihydro-
Fentrazamide metabolite solution is a research chemical that contains trametinib, nebivolol, and other compounds. It is commonly used in laboratory settings for various experiments and studies. This solution is known for its glycoprotein properties, which make it suitable for certain biochemical assays. Additionally, it contains tiagabine hydrochloride, which acts as a racemase inhibitor. The solution also includes diphenyl ether and a plasticizer, which help with the stability and solubility of the compounds. Other components such as colloidal hydroxybenzoic acid, microcapsules, phosphatase inhibitors, l-lysine, and lithium are present to enhance the overall performance of the solution in different applications. Researchers and scientists rely on this Fentrazamide metabolite solution to facilitate their investigations and obtain accurate results.
